TD Private Client Wealth’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.34M | Sell |
4,672
-90
| -2% | -$25.9K | 0.03% | 303 |
|
|
2025
Q1 | $1.47M | Buy |
4,762
+1,092
| +30% | +$337K | 0.04% | 279 |
|
|
2024
Q4 | $1.29M | Sell |
3,670
-18
| -0.5% | -$6.35K | 0.04% | 306 |
|
|
2024
Q3 | $1.32M | Buy |
3,688
+358
| +11% | +$128K | 0.04% | 322 |
|
|
2024
Q2 | $1.06M | Buy |
3,330
+26
| +0.8% | +$8.28K | 0.03% | 336 |
|
|
2024
Q1 | $759K | Buy |
3,304
+135
| +4% | +$31K | 0.02% | 387 |
|
|
2023
Q4 | $697K | Sell |
3,169
-139
| -4% | -$30.6K | 0.03% | 387 |
|
|
2023
Q3 | $747K | Sell |
3,308
-834
| -20% | -$188K | 0.03% | 354 |
|
|
2023
Q2 | $914K | Sell |
4,142
-248
| -6% | -$54.7K | 0.04% | 352 |
|
|
2023
Q1 | $983K | Sell |
4,390
-281
| -6% | -$62.9K | 0.04% | 330 |
|
|
2022
Q4 | $1.3M | Sell |
4,671
-1,197
| -20% | -$333K | 0.06% | 280 |
|
|
2022
Q3 | $1.23M | Sell |
5,868
-182
| -3% | -$38.1K | 0.06% | 272 |
|
|
2022
Q2 | $1.43M | Sell |
6,050
-777
| -11% | -$183K | 0.07% | 260 |
|
|
2022
Q1 | $1.22M | Buy |
6,827
+998
| +17% | +$179K | 0.05% | 311 |
|
|
2021
Q4 | $1.26M | Sell |
5,829
-2,448
| -30% | -$529K | 0.05% | 308 |
|
|
2021
Q3 | $1.53M | Buy |
+8,277
| New | +$1.53M | 0.07% | 276 |
|
|
2020
Q4 | – | Sell |
-15
| Closed | -$1.52K | – | 1167 |
|
|
2020
Q3 | $1.52K | Hold |
15
| – | – | ﹤0.01% | 937 |
|
|
2020
Q2 | $1.82K | Hold |
15
| – | – | ﹤0.01% | 921 |
|
|
2020
Q1 | $1.42K | Hold |
15
| – | – | ﹤0.01% | 909 |
|
|
2019
Q4 | $1.32K | Buy |
+15
| New | +$1.32K | ﹤0.01% | 937 |
|